Deals of the day-Mergers and acquisitions

  • December 02, 2022 08:03 AM PST | Reuters
 Deals of the day-Mergers and acquisitions

(Adds Roivant Sciences, Kroger, OMERS, Campari, BlackRock, Nissan) Dec 1 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2055 GMT on Thursday: ** Biotech firm

Read More...

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions

  • December 02, 2022 08:03 AM AEDT | Reuters

(Adds Roivant Sciences, Kroger, OMERS, Campari, BlackRock, Nissan) Dec 1 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2055 GMT on Thursday: ** Biotech firm

Read More...
MEDIA-Naloxone startup pursues FDA approval for over-the-counter swab - WSJ

MEDIA-Naloxone startup pursues FDA approval for over-the-counter swab - WSJ

  • December 01, 2022 09:37 PM AEDT | Reuters

-- Source link: https://bit.ly/3AY6veU -- Note: Reuters has not verified this story and does not vouch for its accuracy

Read More...
UK STOCKS-Factors to watch on Nov 30

UK STOCKS-Factors to watch on Nov 30

  • November 30, 2022 04:58 PM GMT | Reuters

Nov 30 (Reuters) - Britain's FTSE 100 index is seen opening higher on Wednesday, with futures up 0.37%. * RIO TINTO: Rio Tinto plans to invest a further $600 million in renewable energy assets in the

Read More...
UK STOCKS-Factors to watch on Nov 30

UK STOCKS-Factors to watch on Nov 30

  • November 30, 2022 04:58 PM CET | Reuters

Nov 30 (Reuters) - Britain's FTSE 100 index is seen opening higher on Wednesday, with futures up 0.37%. * RIO TINTO: Rio Tinto plans to invest a further $600 million in renewable energy assets in the

Read More...
What to Watch in the Day Ahead - Wednesday, November 30

What to Watch in the Day Ahead - Wednesday, November 30

  • November 30, 2022 06:30 AM PST | Reuters

(The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at . Thomson One users

Read More...
What to Watch in the Day Ahead - Wednesday, November 30

What to Watch in the Day Ahead - Wednesday, November 30

  • November 30, 2022 06:30 AM EST | Reuters

(The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at . Thomson One users

Read More...
BRIEF-Epsilon Healthcare Says Mark Audet Appointed As Chief Financial Officer

BRIEF-Epsilon Healthcare Says Mark Audet Appointed As Chief Financial Officer

  • November 30, 2022 09:42 PM AEDT | Reuters

Nov 30 (Reuters) - Epsilon Healthcare Ltd: * MARK AUDET HAS BEEN APPOINTED AS CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage:

Read More...
BRIEF-Immutep Enters Into Second Clinical Trial Collaboration Agreement With Merck KGaA, Darmstadt, Germany, And Pfizer For New Combination Study Of Its First-In-Class Lag-3 Candidate, Eftilagimod Alpha, And Avelumab To Treat Urothelial Cancer

BRIEF-Immutep Enters Into Second Clinical Trial Collaboration Agreement With Merck KGaA, Darmstadt, Germany, And Pfizer For New Combination Study Of Its First-In-Class Lag-3 Candidate, Eftilagimod Alpha, And Avelumab To Treat Urothelial Cancer

  • November 30, 2022 12:01 AM PST | Reuters

Nov 29 (Reuters) - Immutep Ltd: * IMMUTEP ENTERS INTO SECOND CLINICAL TRIAL COLLABORATION AGREEMENT WITH MERCK KGAA, DARMSTADT, GERMANY, AND PFIZER FOR NEW COMBINATION STUDY OF ITS FIRST-IN-CLASS LAG-

Read More...
UK STOCKS-Factors to watch on Nov 30

UK STOCKS-Factors to watch on Nov 30

  • November 30, 2022 04:58 PM AEDT | Reuters

Nov 30 (Reuters) - Britain's FTSE 100 index is seen opening higher on Wednesday, with futures up 0.37%. * RIO TINTO: Rio Tinto plans to invest a further $600 million in renewable energy assets in the

Read More...
BRIEF-Little Green Pharma Says Received Ethics Approval For Cbd Phase Iii Clinical Trial

BRIEF-Little Green Pharma Says Received Ethics Approval For Cbd Phase Iii Clinical Trial

  • November 30, 2022 12:36 PM AEDT | Reuters

Nov 30 (Reuters) - Little Green Pharma Ltd: * RECEIVED ETHICS APPROVAL FOR CBD PHASE III CLINICAL TRIAL Source text for Eikon: Further company coverage:

Read More...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK